Related Parties (Details narrative) - USD ($)		1 Months Ended		6 Months Ended
	Jan. 09, 2023	Jan. 31, 2024	Mar. 21, 2023	Jun. 30, 2024	Jun. 25, 2024	May 30, 2024	Dec. 31, 2023
Common stock shares issued				757,340			702,662
Business Combination, Description	Mr. Jenkins and his affiliates received 1,325.838 shares of Series X Convertible Preferred Stock in the merger, and Mr. Jenkins’ adult children received 1,284.344 shares of Series X Convertible Preferred Stock in the merger, all in exchange for their equity interests in Old Catheter in accordance with the merger exchange ratio
Convertible Promissory Notes	$ 25,100,000
Convertible Notes	7,856,251
Interest accrued	$ 13,900,000
Accrued expenses	$ 1,400,000
Options to purchase	14,416
Mr. Jenkins [Member]
Common stock shares issued			99,182
Accrued expenses	$ 1,100,000
Loan amount					$ 150,000	$ 500,000
Interest rate on loan					8.00%	8.00%
Options to purchase	14,416
Number of options	14,081
Remaining number of options	335
Conversion of stock description			conversion of 991.828 shares of Series X Convertible Preferred Stock, and 23,532 shares of common stock to his adult children upon conversion of 235.320 shares of Series X Convertible Preferred Stock
Exercise price	$ 5.90
Remaining number of options exercise price	$ 20.20
Chief Commercial Officer [Member] | May 01, 2024 [Member]
Received options to purchase common stock				25,000
Option exercise price				$ 5.321
Vested percentage				20.00%
Vested period				5 years
Margrit Thomassen [Member]
Received options to purchase common stock		2,500		1,676
Option exercise price		$ 4.00		$ 5.90
Vested percentage		20.00%
Vested period		5 years